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Background: Recently, there has been renewed interest in the development of
minimally invasive procedures to treat atrial fibrillation. Unipolar radiofrequency
catheters are plagued by poor results, in part because of their inability to produce
transmural lesions. This study tested the ability of bipolar radiofrequency energy to
create chronic transmural lesions on the beating heart that isolated atrial myocar-
dium.
Methods: Five sheep underwent a right thoracotomy. Baseline pacing was per-
formed from the following targeted areas: right atrial appendage, superior vena
cava, inferior vena cava, and right pulmonary veins. A cuff of atrial myocardium
around the targeted tissue was clamped between the 2 arms of the device. Radio-
frequency energy was delivered at 750 mA and continued until the tissue conduc-
tance between the electrodes reached a stable minimum level. After ablation, pacing
was used to document tissue isolation. The animals survived for 30 days.
Results: Twenty circumferential lesions were produced at the initial operation. The
mean ablation time was 9.3  4.0 seconds, and the mean peak temperature was
48.4°C  6.4°C. All lesions acutely and chronically isolated the targeted tissue.
Trichrome staining showed that all lesions were transmural. There were no instances
of pulmonary vein stenosis or thrombosis.
Conclusions: Bipolar radiofrequency energy can produce permanent transmural
linear lesions on the beating heart. Online measurement of tissue conductance
reliably predicted lesion transmurality. This new technology may enable surgeons to
perform a curative minimally invasive operation for atrial fibrillation on the beating
heart.
Atrial fibrillation is the most common dysrrhythmia in the UnitedStates, with an incidence of 2% in the general population.1 In theelderly the incidence can be as high as 6%. Even with theaggressive treatment of atrial fibrillation, there still exists a sig-nificant mortality and morbidity from this disease. Patients are atan increased risk for stroke and other thromboembolic disease.2,3
They also have increased morbidity as a result of atrioventricular dysynchrony and
compromised hemodynamics. It is estimated that atrial fibrillation accounts for 1.4
million outpatient visits and 227,000 hospitalizations each year in the United States
alone.4 The current medical regimen consists of anticoagulation, as well pharma-
cologic strategies designed both to control heart rate and to convert the patient to
normal sinus rhythm. This regimen, although effective in treating the symptoms of
the disease, is by no means a cure. The patient is left with the significant morbidity
of anticoagulation and the side effects of the antiarrhythmic drugs. Moreover, rate
control alone does not address the impaired hemodynamics or thromboembolic risk.
The development of the Cox maze procedure has offered a cure for atrial
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fibrillation.5 This surgical approach has achieved success
rates of greater than 90%, and it has been established as the
gold standard against which other interventions are judged.
The Cox maze procedure is based on the theory that atrial
fibrillation is the result of macroreentrant circuits.6 By abol-
ishing these circuits with lines of conduction block created
by means of carefully placed surgical incisions, atrial fibril-
lation can be eliminated. Despite the clinical success of the
maze procedure, it has not gained widespread acceptance
because of its invasiveness and the length of time required
to create the complicated set of lesions. Recently, interest
has turned toward the development of a less invasive pro-
cedure. Ideally, this procedure would require less operative
time, could be performed through a small incision or endo-
scopically, and would not require a prolonged period of
cardiopulmonary bypass and cardioplegic arrest.
Over the past 10 years, there have been significant ad-
vances in the development of radiofrequency (RF) energy as
a means to ablate myocardial tissue.7 This energy, delivered
in an epicardial or endocardial manner, is capable of pro-
ducing myocardial necrosis and has the ability to electri-
cally isolate myocardial tissue. RF energy has been used by
electrophysiologists in the ablation of accessory pathways
and atrioventricular node reentry with significant success.8
There also has been much interest in RF ablation for the
treatment of atrial fibrillation. However, difficulty remains
in use of catheter-based techniques to create reproducible
transmural lesions. These procedures have required lengthy
fluoroscopic exposure times and have been plagued both by
a high incidence of complications and low success rates.9,10
The lack of success of catheter-based techniques has led to
a resurgence of interest in surgical procedures to treat atrial
fibrillation. Unfortunately, unipolar RF energy cannot reli-
ably create transmural ablation on the beating heart.11 Our
goal was to investigate whether RF energy delivered by
means of a bipolar device could reproducibly create lesions
in a rapid and controlled manner that was capable of elec-
trically isolating myocardial tissue.
Methods
Five adult sheep weighing 35 to 45 kg were used in this study. The
animals were initially anesthetized with intramuscular ketamine
(30 mg/kg), followed by inhaled 3% isoflurane. Arterial and ve-
nous access were achieved through a cut down of the carotid artery
and external jugular vein, respectively. The arterial pressure and
electrocardiographic results were monitored continuously. A 7-cm
right anterolateral thoracotomy was made in the fourth intercostal
space. The pericardium was opened, and the right atrium and both
vena cavae were exposed. The inferior vena cava (IVC), superior
vena cava (SVC), and right pulmonary veins (RPVs) were circum-
ferentially dissected and isolated with umbilical tape. The lesion
set in this study was designed to maximize the potential circum-
ferential lesion site to evaluate electrical isolation by pacing stud-
ies and does not represent a variation of the Cox maze procedure.
The heart was paced from the right atrial body and appendage,
and pacing thresholds were recorded. Pacing was also performed
from the right-sided pulmonary veins, as well as from both vena
cavae, at a distance of 1 cm from the atriocaval junction. The
animal was given intravenous heparin (200 U/kg), and an activated
clotting time of greater than 200 seconds was maintained through-
out the study.
A bipolar RF ablation device was used to create the lesions
(Atricure Inc, Cincinnati, Ohio). The RF generator is able to
control both voltage and current delivery to the electrodes. A
laptop computer with Labview version 5.1 (National Instruments,
Austin, Tex) was used to monitor and record temperature, time,
current, voltage, impedance, conductance, and energy. Tempera-
ture was recorded 1 mm from the electrode edge. The computer
system displayed these variables in a real-time continuous graphic
format.
Atrial lesions were created by clamping target tissue between
the 2 electrode arms of the device. A cuff of atrial myocardium
was ablated around the right atrial appendage (RAA), SVC, IVC,
and right-sided pulmonary veins. RF energy was delivered at 75 V
and 750 mA. The ablation was continued until the tissue conduc-
tance between the 2 electrodes decreased and achieved a steady
state for 2 seconds (Figure 1). Tissue conductance was chosen as
an indicator of a complete transmural ablation. Electrical isolation
was defined as the inability to capture the body of the right atrium
by pacing inside the isolated segment with a stimulus strength of
20 mA. The animals survived for 30 days after ablation. The
animals received 325 mg of aspirin each morning after the oper-
ation.
On day 30, a median sternotomy was performed, and the heart
was exposed. Pacing at 10 mA was used to document chronic
electrical isolation. The animal was put to death with sodium
pentobarbital, and the heart was excised en bloc. The atrium and
pulmonary veins were examined for any evidence of thrombus or
stricture. The RF lesions were grossly examined, and tissue was
stained with Masson Trichrome to assess transmurality.
All animals received humane care in compliance with the
“Guide for the Care and Use of Laboratory Animals” published by
the National Institutes of Health (National Institutes of Health
publication no. 85-23, revived 1985).
Results
Operative Results
In one animal it was not possible to dissect circumferen-
tially around the IVC or RPVs because of adhesions present
at the initial operation. There were no intraoperative com-
plications or postoperative morbidity or mortality in this
series. The animals were continuously monitored in the
immediate postoperative period (48 hours) and remained in
normal sinus rhythm. Preoperatively and at 30 days, all the
animals were in normal sinus rhythm.
RF Lesion Delivery
A total of 20 circumferential lesions were performed on
cuffs of atrial myocardium surrounding the SVC, IVC, and
RPVs and on the RAA (Table 1). In the last 2 animals, a
second RAA lesion was created to connect the initial RAA
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lesion and to produce an isolated section of myocardium. In
both animals the lesion lines overlapped smoothly, and the
enclosed myocardium was isolated (Figure 2).
The mean ablation time was 9.3  4.0 seconds (range,
6-23.2 seconds), with a mean peak temperature of 48.3°C
6.4°C. For lesions (n  7) created on the RAA, the mean
ablation time was 9.4  3.4 seconds (range, 6.5-14.8 sec-
onds), and the mean peak temperature was 47.1°C  6.9°C.
The wall thickness of the RAA ranged from 2 to 2.5 mm.
The average energy delivered was 168.6  68.9 J.
For lesions (n  5) created on the SVC, the mean
ablation time was 11.7  6.6 seconds (range, 7-23.2 sec-
onds), with a mean peak temperature of 51.7°C  8.6°C.
The wall thickness of the SVC ranged from 0.5 to 0.8 mm.
The average energy delivered was 267.6  257.2 J.
For lesions (n 4) created on the IVC, the mean ablation
time was 7.4  0.9 seconds (range, 6.3-8.2 seconds), with a
mean peak temperature of 46.7°C  2.5°C. The wall thick-
ness of the IVC ranged from 0.4 to 0.8 mm. The average
energy delivered was 101.0  16.43 J.
For lesions (n  4) created on the RPVs, the mean
ablation time was 7.7  1.3 seconds (range, 6.0-9.0 sec-
onds), with a mean peak temperature of 48.1°  5.9°C. The
wall thickness of the RPVs varied depending on the fat pad
surrounding the RPV–right atrium junction (range, 1.1-5
mm). The average energy delivered was 102.3  38.5 J.
Pacing Results
Before ablation, pacing was performed from all potential
target tissues sites (20/20) 1 cm distal to the junction with
the atrial myocardium. Pacing thresholds were less than or
Figure 1. A real-time graph of tissue conductance (measured in Mhos on the Y axis) between the 2 electrodes on
the arms of the device and time (measured in seconds on the X axis). This graph was taken from an RAA lesion
on the beating heart. It shows the decrease in tissue conductance at 5.5 seconds and a stable minimal level
afterward. Energy was delivered for 11 total seconds during this ablation.
Figure 2. An in vivo picture of 2 connecting lesions of the body of
the right atrium. These 2 lines of block electrically isolated the
appendage from the body of the right atrium.
TABLE 1. Ablation summary
Lesion







RAA 7 9.4 3.4 47.1 6.9 100% 100%
SVC 5 11.68 6.6 51.7 8.6 100% 100%
IVC 4 7.4 0.9 46.7 2.5 100% 100%
RPV 4 7.7 1.3 48.1 5.9 100% 100%
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equal to 1.5 mA at every site. After ablation, pacing stimuli
from all sites were unable to capture the body of the right
atrium at stimulus strengths of up to 20 mA. Thus electrical
isolation was documented for all 20 ablation lesions. After
30 days, pacing studies documented continued isolation in
all 20 lesions.
Histology
Examination of the atria, vena cavae, and pulmonary veins
revealed no evidence of thrombus or stricture formation. All
lesions were examined postmortem by using Masson
Trichrome staining. Histology demonstrated replacement of
atrial myocardium at the ablation site with fibrin and colla-
gen matrix. All lesions were transmural, continuous, and
linear (Figures 3 and 4). The lesion width was discrete and
varied depending on the depth and time of the lesion. In
areas of thin walls (ie, IVC and SVC), the lesion width was
fairly constant at 1 mm. On thicker areas of the atrium (ie,
the appendage), where the wall thickness was up to 5 mm,
the lesion width was increased but never greater than 2 mm.
An interesting finding in this study was that despite
creating a transmural lesion that completely isolated elec-
trical activity in the RAA, the appendage remained viable,
with no evidence of necrosis (Figure 5). This indicates that
although bipolar RF energy causes transmural necrosis of
myocardial tissue, it might preserve the microvasculature, at
least to the RAA. Further studies are needed to investigate
this hypothesis.
Discussion
Atrial fibrillation is a major source of morbidity, particu-
larly in the elderly population.3 Despite advances in trans-
venous endocardial catheter-based techniques, there is still
no consistent cure for atrial fibrillation, except the surgical
Cox maze procedure. The Cox maze procedure creates
transmural lesions in the myocardium with a scalpel that
forms the lines of conduction block, terminating the reen-
trant circuits that cause AF. Unfortunately, alternative epi-
cardial and endocardial energy sources have failed to pro-
duce transmural lesions in a consistent fashion. This might
be one of the reasons for the lower success rates seen after
catheter-based procedures.12,13
Unipolar RF catheters require ablation times measured in
minutes, and multiple applications are often required to
produce a transmural lesion. These catheters produce elec-
trode temperatures of between 80°C and 90°C and can cause
severe thermal injury to adjacent tissue. The biggest limi-
tation of epicardial unipolar RF ablation is that it is nearly
impossible to make a transmural lesion on the beating heart
because of the intracavitary heat sink caused by the circu-
lating blood volume. This shortcoming is compounded by
the fact that physicians have no way of determining the
depth or transmurality of the lesion with presently available
unipolar RF endocardial and epicardial catheters. A final
challenge of ablation with unipolar catheters is the need to
maintain constant approximation to the tissue. The physics
of RF energy ablation are based on the theory that the
energy source and the tissue must be in intimate contact.12
Figure 3. An ex vivo picture of the superior RPV. The device is able to isolate a cuff of atrial tissue at the RPV–left
atrial junction by producing a continuous linear lesion circumferentially around the targeted tissue. There was no
gross pulmonary vein stenosis or thrombosis.
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Uneven pressure or a momentary lapse of contact increases
the energy required and results in nonuniformity of the
lesion.
There is a pressing clinical need for a device that can
reproducibly and reliably perform full-thickness endocar-
dial and epicardial ablation. The bipolar RF device used in
this study was able to meet these clinical needs. The catheter
was able to consistently produce transmural linear lesions.
The time required to produce a transmural linear lesion of
up to 5 cm in length averaged only 9 seconds. By shortening
the time required to produce a functional lesion, the tissue
was exposed to less energy and less heat. The surface
temperature of the electrode was maintained at more phys-
iologic levels (40°C-60°C), and peak temperature 1 mm
Figure 4. An ex vivo picture of a lesion at the junction of the SVC and the body of the right atrium after 30 days.
The anterior portion of the right atrium was opened so that the lesion could be better visualized. The lesion was
continuous, linear, and discrete.
Figure 5. A lesion on the anterior surface of the RAA stained with Masson Trichrome stain. (Original magnification
10.) In every instance the RAA tip was viable, and the lesion was transmural. In this ablation the width of the
lesion was 1.3 cm, and the depth was 2.5 cm.
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from the electrode was significantly lower than the 80°C to
90°C achieved with unipolar RF catheters.
Histologic evaluation documented that the lesions were
discrete, with minimal damage of the surrounding tissue.
Average lesion width was less than 2 mm. This is even less
damage then seen with a traditional surgical incision. Hy-
pothetically, this might result in a better preservation of
atrial transport function, one of the critical outcome mea-
surements after the Cox maze procedure. The lower tem-
peratures and more discrete lesions should decrease the risk
of both intraoperative and postoperative thromboembolic
complications or stricture. No intracavitary thrombi were
found in this chronic study. Moreover, there was also no
evidence of pulmonary vein stenosis. This complication has
been reported to be as high as 39% acutely and 8% chron-
ically after unipolar RF ablation.14,15 This is further testi-
mony to the lack of collateral tissue damage with this
technique.
The computer system provided with this bipolar RF
device monitored multiple variables in a graphic format.
Temperature, current, impedance, conductance, voltage, en-
ergy, and time are continuously displayed in real time. This
provides the surgeon with instantaneous feedback as to the
progress of the lesion during ablation. Changes in tissue
conductance provided a 100% correlation with lesion trans-
murality in this study. As the lesion progressed through the
myocardium, the tissue conductance decreased between the
electrodes. Once the lesion became transmural, the tissue
conductance reached a plateau and did not change. This is
the first reported device to have an online measurement of
transmurality. This has the advantage of allowing the sur-
geon to stop ablation as soon as the lesion is completed,
protecting the atrial myocardium from unnecessary energy,
excessive necrosis, and scarring.
This chronic survival study has demonstrated, for the
first time, an efficacious method to create transmural atrial
lesions from the epicardium on the beating heart. This
technology has the potential to treat atrial fibrillation in a
definitive, safe, and expeditious manner. A beating-heart
maze procedure would eliminate the morbidity of placing
patients on cardiopulmonary bypass and crossclamping the
aorta and at the same time offer a more reliable cure of this
arrhythmia compared with that provided by catheter-based
techniques. This technology also has the potential to be used
endoscopically, allowing for a truly minimally invasive
procedure. Although these initial results are promising, clin-
ical studies are needed to examine the effectiveness of these
lesions in treating atrial fibrillation.
We thank Diane Toeniskoetter, Kathy Fore, and Dennis Gor-
don for their technical assistance.
References
1. Cameron A, Schwartz MJ, Kronmal RA, Kosinski AS. Prevalence and
significance of atrial fibrillation in coronary artery disease (CASS
registry). Am J Cardiol. 1988;61:714-7.
2. Reeder AS, Sastry BS, Thomas TP, et al. Atrial fibrillation and stroke
in elderly hospitalized patients. Age Aging. 1986;15:89-92.
3. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic
assessment of chronic atrial fibrillation and risk of stroke: the Fra-
mingham study. Neurology. 1979;28:973-7.
4. National Center for Health Statistics. Public use data tape documen-
tation: 1995 National Ambulatory Medical Care Survey. Hyattsville,
MD: National Center for Health Statistics, US Public Health Service;
1997.
5. Smith PK, Holman WL, Cox JL. Surgical treatment of supraventicular
tachyarrhythmias. Surg Clin North Am. 1985;65:553-70.
6. Cox JL, Canavan TE, Schuessler RB, et al. The surgical treatment of
atrial fibrillation: II. Intraoperative electrophysiologic mapping and
description of the electrophysiologic basis of atrial flutter and atrial
fibrillation. J Thorac Cardiovasc Surg. 1991;101:406-26.
7. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence
and prognosis and predisposing conditions for atrial fibrillation: pop-
ulation-based estimation. Am J Cardiol. 1998;82:2N-9N.
8. Jazayeri MR, Hempe SL, Sra JS, et al. Selective transcatheter ablation
of the fast and slow pathways using radiofrequency energy in patients
with atrioventricular nodal reentrant tachycardia. Circulation. 1992;
85:1318-28.
9. Jais P, Shah DC, Haissaguerre M, et al. Efficacy and safety of septal
and left-atrial linear ablation for atrial fibrillation. Am J Cardiol.
1999;84:139R-46R.
10. Dagres N, Clague JR, Lottkamp H, Hindricks G, Breithardt G, Borg-
grefe M. Impact of radiofrequency catheter ablation of accessory
pathways on the frequency of atrial fibrillation during long-term
follow-up: high recurrence rate of atrial fibrillation in patients older
than 50 years of age. Eur Heart J. 2001;22:423-7.
11. Hoenicke EM, Strange RG Jr, Patel H, Prophet GA, Damiano RJ Jr.
Initial experience with epicardial radiofrequency ablation catheter in
an ovine model: moving towards an endoscopic maze procedure. Surg
Forum. 2000;81:79-82.
12. Xie B, Heald SC, Camm AJ, Rowland E, Ward DE. Radiofrequency
catheter ablation of accessory atrioventricular pathways: primary fail-
ure and recurrence of conduction. Heart. 1997;77:363-8.
13. Rosenthal LS, Mahesh M, Beck TJ, et al. Predictors of fluoroscopy
time and estimated radiation exposure during radiofrequency catheter
ablation procedures. Am J Cardiol. 1998;82:451-8.
14. Yu WC, Hsu TL, Tai CT, et al. Acquired pulmonary vein stenosis after
radiofrequency catheter ablation of paroxysmal atrial fibrillation.
J Cardiovasc Electrophysiol. 2001;12:887-92.
15. Gerstenfeld EP, Guerra P, Sparks PB, Hattori K, Lesh MD. Outcome
after radiofrequency catheter ablation of focal atrial fibrillation trig-
gers. J Cardiovasc Electrophysiol. 2001;12:900-8.
Prasad et al Surgery for Acquired Cardiovascular Disease
The Journal of Thoracic and Cardiovascular Surgery ● Volume 124, Number 4 713
A
CD
